Joachim Yahalom, MD

This management guide covers the risk factors, screening, diagnosis, staging, and treatment of Hodgkin lymphoma.

After more than two decades of successful laboratory and clinical research, the "new" entity of mucosa-associated lymphoid tissue (MALT) lymphoma is reaching a noble maturity.

In 2009 approximately 8,510 new cases of Hodgkin lymphoma (HL) will be diagnosed in the United States. Over the past 4 decades, advances in radiation therapy and the advent of combination chemotherapy have tripled the cure rate of patients with HL. In 2009, more than 80% of all newly diagnosed patients can expect a normal, disease-free life span.

In the year 2005, approximately 8,000 new cases of Hodgkin's lymphoma (HL)will be diagnosed in the United States. Over the past 4 decades, advances inradiation therapy and the advent of combination chemotherapy have tripledthe cure rate of patients with HL. In 2005, more than 80% of all newly diagnosedpatients can expect a normal, disease-free life span.